Comparing a Daily Versus Weekly Titration Algorithm in People with Type 2 Diabetes Switching from Basal Insulin to Iglarlixi in the LixiLan ONE CAN Randomized Trial
Diabetes, Obesity and Metabolism（2022）
关键词
basal insulin,GLP-1 analogues,glycaemic control,phase III,randomized trial,type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要